MarketLens

Assertio's Acquisition: What's the Deal and Why Now

3 months ago

SHARE THIS ON:

Assertio's Acquisition: What's the Deal and Why Now

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Why is SUMA Acquisition Corporation Launching Now

Why is SUMA Acquisition Corporation Launching Now

5 months ago

Is the Fox Acquisition a Fair Deal for Roku Shareholders

Is the Fox Acquisition a Fair Deal for Roku Shareholders

2 months ago

What Led to Yotta Acquisition Corp.'s Latest Deal Termination

What Led to Yotta Acquisition Corp.'s Latest Deal Termination

5 months ago

What is Seagate Technology Holdings and Why Does it Matter Now

What is Seagate Technology Holdings and Why Does it Matter Now

3 months ago

Category

Top Featured Pro Only Stock Analysis Investment Ideas ETFs Crypto

You may also like

Stock News•2 weeks ago

Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio

Jazz Pharmaceuticals agreed to acquire Actio Biosciences for $820M upfront plus up to $500M in milestones, adding ABS-1230, a first-in-class KCNT1+ epilepsy therapy, leveraging Jazz's rare-epilepsy co...

Stock News•3 weeks ago

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

AstraZeneca and Bristol Myers Squibb are in potential merger talks to form a ~$400B pharma giant, per weekend media reports. Deal economics and patent expirations are now in focus for investors.

Stock News•3 weeks ago

Collegium Pharmaceutical: Pain Cash Flows Are Funding An ADHD Re-Rating

Collegium Pharmaceutical is shifting to a CNS platform, using stable pain cash flows to fund ADHD growth. The $350M cash and $300M debt AZSTARYS acquisition is expected to add $60–70M revenue in 2026 ...

Stock News•1 months ago

Vertex Pharmaceuticals Incorporated (VRTX) M&A Call Transcript

Vertex Pharmaceuticals held an M&A call to discuss its acquisition strategy. The call likely covered deal rationale and financial implications for the company.

Breaking News

Semiconductor Stocks

Biotech & Pharma

Corporate Earnings

Personal Consumption Expenditures (PCE)

Valuation Multiples

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

2 weeks ago

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

2 weeks ago

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

2 weeks ago

Top Headlines

Stock News•39 minutes ago

NVIDIA Reports +120% Earnings Growth: Ho-Hum, Just Another Day

Stock News•47 minutes ago

INTU FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Intuit Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 8 Deadline in Securities Class Action Filed by the Firm- INTU

Stock News•53 minutes ago

NVIDIA Q2 Earnings Call Highlights

Stock News•1 hour ago

Nvidia forecasts quarterly revenue above estimates, shares rise

Stock News•1 hour ago

CEO Jensen Huang went on an AI deal spree in August. Nvidia plans to invest $18 billion more this fiscal year.